Delivery Order SPE2DB22D3016-SPE2DB26FAAT7
- Not listed
- The Defense Logistics Agency awarded a $13,720.40 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.42 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company will perform the work from its Corporate Office...
- The Defense Logistics Agency awarded a $20,986.24 delivery order contract to AmerisourceBergen Drug Corp for Act-O-Vials on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,949.28 to AmerisourceBergen Drug Corp for Act-O-Vials on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $108,033.00 to AmerisourceBergen Drug Corp for Act-O-Vials on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is non-set-aside and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.60 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,744.08 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for Act-o-Vials on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on October 31, 2025, with an ultimate completion date of November 3, 2025. This firm fixed price contract is non-competitive and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.08 to AmerisourceBergen Drug Corp for ACT-O-VIALS on October 22, 2025, with completion scheduled for October 23, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAT7Delivery Order
The Defense Logistics Agency awarded a $20,883.59 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC enables the company to supply an extensive portfolio of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers globally. This delivery order for Act-O-Vials continues the company's role as a primary vendor within DLA's pharmaceutical supply chain, supporting the military healthcare enterprise with essential medical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 10/28/25 |